 |
인쇄하기
취소
|
Ilyang recognized as foreign quasi-drug manufacturer in Japan
Ilyang Pharm said Tuesday its Yongin plant has been recognized as an eligible foreign manufacturing facility of quasi-drugs from the Japanese Health, Labor and Welfare.
Under the Japanese health ministry’s recognition, several quasi-drugs of Ilyang brands will be available in large marts, convenience stores and pharmacy chains throughout Japan.
The company is now making an inroad to overs...
Under the Japanese health ministry’s recognition, several quasi-drugs of Ilyang brands will be available in large marts, convenience stores and pharmacy chains throughout Japan.
The company is now making an inroad to overs...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.